Search research articles

Search research articles

Related Experiment Videos

Methylglyoxal can modify GAPDH activity and structure.

Hyon Jae Lee¹, Scott K Howell, Rebecca J Sanford

¹Dartmouth Medical School, Dartmouth-Hitchcock Medical Center, 1 Medical Center Drive, Lebanon, NH 03756, USA.

Annals of the New York Academy of Sciences

|July 23, 2005

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Impact of atrial fibrillation and atrial fibrillation therapies on sports performance in athletes.

Heart rhythm·2024

Same author

Plasma AGE and Oxidation Products, Renal Function, and Preeclampsia in Pregnant Women with Type 1 Diabetes: A Prospective Observational Study.

Journal of diabetes research·2023

Same author

Sex Differences in Periprocedural and Long-Term Outcomes Following Transcatheter Left Atrial Appendage Occlusion: A Systematic Review and Meta-Analysis.

Cardiovascular revascularization medicine : including molecular interventions·2022

Same author

Plasma Levels of Advanced Glycation Endproducts and Risk of Cardiovascular Events: Findings From 2 Prospective Cohorts.

Journal of the American Heart Association·2022

Same author

Response to Comment on Koska et al. Advanced Glycation End Products Predict Loss of Renal Function and High-Risk Chronic Kidney Disease in Type 2 Diabetes. Diabetes Care 2022;44:684-691.

Diabetes care·2022

Same author

Advanced Glycation End Products Predict Loss of Renal Function and High-Risk Chronic Kidney Disease in Type 2 Diabetes.

Diabetes care·2022

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Methylglyoxal (MG) exposure significantly reduces glyceraldehyde-3-phosphate dehydrogenase (GAPDH) activity and alters its structure. These findings suggest elevated MG levels in vivo may impair GAPDH function, contributing to diabetic complications.

Area of Science:

Biochemistry
Enzymology
Metabolic pathways

Background:

Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is crucial in metabolic regulation and implicated in diabetic complications.
Metabolic factors like oxidative and glycation products can modify GAPDH activity.
Methylglyoxal (MG) is a potent alpha-dicarbonyl sugar implicated in glycation.

Purpose of the Study:

To investigate the structural and activity-based effects of methylglyoxal (MG) glycation on glyceraldehyde-3-phosphate dehydrogenase (GAPDH).

Main Methods:

Rabbit GAPDH was incubated with varying concentrations of MG (10-1000 microM) for 96 hours.
Enzyme activity was measured using spectrophotometry.
Changes in isoelectric point (IEP) and mass were analyzed using isoelectric focusing (IEF) with Western blotting and MALDI mass spectrometry, respectively.

Related Experiment Videos

Main Results:

GAPDH activity decreased by up to 97% with 1 mM MG exposure, with a 69.2% reduction observed within 2 hours at 1 mM MG.
MG exposure caused significant shifts in GAPDH's isoelectric point (from 8.5 to 7.5 with 1 mM MG) and increased its mass, indicating glycation.
MALDI analysis revealed the addition of multiple MG residues to GAPDH, correlating with MG concentration.

Conclusions:

Methylglyoxal can modify GAPDH structure and significantly reduce its enzymatic activity at concentrations relevant to in vivo conditions.
These MG-induced modifications suggest a potential mechanism by which elevated intracellular MG contributes to the pathogenesis of diabetic complications by impairing GAPDH function.